These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10720807)

  • 21. CTX-M-3-type extended-spectrum beta-lactamase-producing Morganella morganii: first description of an isolate from Turkey.
    Metan G; Gulmez D; Eser OK; Kocagöz S; Sardan YC; Hascelik G
    Int J Antimicrob Agents; 2007 Oct; 30(4):368-70. PubMed ID: 17644345
    [No Abstract]   [Full Text] [Related]  

  • 22. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM; Maskell JP; Sehgal SC; Williams JD
    Infection; 1989; 17(3):165-7. PubMed ID: 2737760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of resistance to quinolones.
    Cambau E; Gutmann L
    Drugs; 1993; 45 Suppl 3():15-23. PubMed ID: 7689446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation, identification and characterization of Morganella morganii from Naja naja atra in Beijing, China.
    Wang HF; Du LY; Luo J; He HX
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):52-58. PubMed ID: 28838340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel class 1 integron (In1390) harboring bla
    Moura Q; Cerdeira L; Fernandes MR; Vianello MA; Lincopan N
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):345-347. PubMed ID: 29628289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antimicrobial sensitive of Morganella morganii].
    Zalas-Wiecek P; Michalska A; Sielska B; Gospodarek E
    Med Dosw Mikrobiol; 2011; 63(2):155-62. PubMed ID: 22184910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. War wound treatment complications due to transfer of an IncN plasmid harboring bla(OXA-181) from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli.
    McGann P; Snesrud E; Ong AC; Appalla L; Koren M; Kwak YI; Waterman PE; Lesho EP
    Antimicrob Agents Chemother; 2015; 59(6):3556-62. PubMed ID: 25870058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel cfr-carrying Tn7 transposon derivative characterized in Morganella morganii of swine origin in China.
    Chen Y; Lei C; Zuo L; Kong L; Kang Z; Zeng J; Zhang X; Wang H
    J Antimicrob Chemother; 2019 Mar; 74(3):603-606. PubMed ID: 30508103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
    Cohen SP; Hooper DC; Wolfson JS; Souza KS; McMurry LM; Levy SB
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1187-91. PubMed ID: 3056253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M; Greenwood D
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G; Pozzetto B; Dorche G
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii.
    Power P; Galleni M; Ayala JA; Gutkind G
    Antimicrob Agents Chemother; 2006 Mar; 50(3):962-7. PubMed ID: 16495258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.
    Chevalier J; Pagès JM; Eyraud A; Malléa M
    Biochem Biophys Res Commun; 2000 Aug; 274(2):496-9. PubMed ID: 10913366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants.
    Rohner P; Peebo M; Lew DP; Auckenthaler R; Pechère JC
    J Antimicrob Chemother; 1992 Jan; 29(1):41-8. PubMed ID: 1737723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and natural antibiotic susceptibility of Morganella morganii.
    Stock I; Wiedemann B
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):153-65. PubMed ID: 9572021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of In116, the first blaCTX-M-2-containing complex class 1 integron found in Morganella morganii isolates from Buenos Aires, Argentina.
    Power P; Galleni M; Di Conza J; Ayala JA; Gutkind G
    J Antimicrob Chemother; 2005 Apr; 55(4):461-5. PubMed ID: 15743901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolone antimicrobial agents: mechanism of action and resistance development.
    Bryan LE; Bedard J; Wong S; Chamberland S
    Clin Invest Med; 1989 Feb; 12(1):14-9. PubMed ID: 2537696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.